Hopp Children's Cancer Center
meet the
Team
Marcel Kool, PhD
Preclinical model systems, high-throughput drug screens, shRNA screens, and CRISPR/Cas9 screens, to find new and better drug targets and for understanding tumor development and primary and acquired therapy-related resistance mechanisms
Stefan M. Pfister, MD
Professor Dr. Stefan Pfister was appointed head of the Division Pediatric Neurooncology at the German Cancer Research Center. Professor Dr. Pfister´s research focuses on the genetic and epigenetic characterization of childhood brain tumors by applying nextgeneration profiling methods and subsequentl
David T.W. Jones, PhD
Our research in the area of HGG & DIPG aims at understanding the heterogeneity both within single tumors and between individuals, to identify the most important patterns of alterations in the cellular machinery. We then try to recapitulate these changes in model systems, in order to understand their
Natalie Jäger, PhD
With our analyses, we significantly support the INFORM program, an international project to create personalized molecular tumor profiles for children with recurrent or refractory tumors. By analyzing the tumor data, we identify molecular changes that may represent potential targets for a given drug
